Kirpalani Anish, Chong Jennifer, Yang Natalie, Jenkins Sarah J, Nisenbaum Rosane, Prabhudesai Vikramaditya, Anthwal Shalini, Colak Errol
Department of Medical Imaging, University of Toronto, St. Michael's Hospital, 30 Bond Street, 3CC, Toronto, ON M5B 1W8, Canada.
Department of Medical Imaging, University of Toronto, St. Michael's Hospital, 30 Bond Street, 3CC, Toronto, ON M5B 1W8, Canada.
Eur J Radiol. 2014 Sep;83(9):1620-5. doi: 10.1016/j.ejrad.2014.05.031. Epub 2014 Jun 7.
To determine the change in apparent diffusion coefficient (ADC) of uterine fibroids following uterine fibroid embolisation (UFE), and if the ADC change correlates with either volume loss or degree of contrast enhancement post-UFE.
This study was approved by our institutional review board with waiver of consent. The pelvic MRI examinations, including diffusion-weighted MRI (DWI) using 4 b-values, of 50 consecutive patients prior to and 6 months post-UFE were analyzed. The volume, ADC and amount of enhancement were calculated for each fibroid both pre- and post-UFE. The percent residual enhancement for each fibroid was categorized as either: no (0-1%) residual enhancement or residual (>1%) enhancement. Statistical analysis compared ADC, enhancement and volume for each fibroid pre- and post-UFE using paired t-tests and Pearson correlation coefficients.
The mean ADC of all (n=88) fibroids pre-UFE was 1.30±0.20×10(-3)mm(2)/s, and increased to 1.68±0.24×10(-3)mm(2)/s post-UFE (p<0.0001). Lower pre-UFE ADC correlated with greater ADC change post-UFE (r=-0.50; p<0.0001). There was no correlation between ADC change and volume change post-UFE (r=0.07; p=0.59). However, fibroids with no residual enhancement post-UFE had larger ADC change than those with residual enhancement (p=0.003).
The ADC of fibroids rises post-UFE. ADC change post-UFE is associated with the degree of loss of enhancement and may therefore be valuable in predicting response to treatment in pre-procedural counseling.
确定子宫肌瘤栓塞术(UFE)后子宫肌瘤的表观扩散系数(ADC)变化,以及ADC变化是否与UFE后的体积缩小或对比增强程度相关。
本研究经机构审查委员会批准,豁免了知情同意。分析了50例连续患者在UFE前和UFE后6个月的盆腔MRI检查,包括使用4个b值的扩散加权MRI(DWI)。计算每个肌瘤在UFE前后的体积、ADC和增强量。每个肌瘤的残余增强百分比分为:无(0-1%)残余增强或残余(>1%)增强。使用配对t检验和Pearson相关系数对每个肌瘤在UFE前后的ADC、增强和体积进行统计分析。
所有(n=88)肌瘤在UFE前的平均ADC为1.30±0.20×10(-3)mm(2)/s,UFE后增加到1.68±0.24×10(-3)mm(2)/s(p<0.0001)。UFE前较低的ADC与UFE后较大的ADC变化相关(r=-0.50;p<0.0001)。UFE后ADC变化与体积变化之间无相关性(r=0.07;p=0.59)。然而,UFE后无残余增强的肌瘤比有残余增强的肌瘤有更大的ADC变化(p=0.003)。
UFE后肌瘤的ADC升高。UFE后ADC变化与增强丧失程度相关,因此在术前咨询中预测治疗反应可能有价值。